FITB
35
2
SCHW
40
3
GT
47
4
AMP
50
3
ES
29
3
NTAP
60
2
SLG
38
3
HOG
29
2
TGNA
50
2
PWR
66
3
IBM
54
3
CNP
54
4
DOW
47
3
HP
38
4
CHRW
54
3
DIS
72
4
R
61
2
BF.B
35
2
GWW
51
3
CMCSA
52
3
FITB
35
2
SCHW
40
3
GT
47
4
AMP
50
3
ES
29
3
NTAP
60
2
SLG
38
3
HOG
29
2
TGNA
50
2
PWR
66
3
IBM
54
3
CNP
54
4
DOW
47
3
HP
38
4
CHRW
54
3
DIS
72
4
R
61
2
BF.B
35
2
GWW
51
3
CMCSA
52
3
Financhill
Back

Acumen Pharmaceuticals 10K Form

Sell
11

ABOS
Acumen Pharmaceuticals

Last Price:
$1.80
Seasonality Move:
-0.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ABOS News And Ratings

See the #1 stock for the next 7 days that we like better than ABOS

ABOS Financial Statistics

Sales & Book Value

Annual Sales: $1.4M
Cash Flow: $-24.6M
Price / Cash Flow: 0
Annual Sales: $3.62
Price / Book: 0.5

Profitability

EPS (TTM): -1.38000
Net Income (TTM): $-81.7M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Acumen Pharmaceuticals Earnings Forecast

Key Acumen Pharmaceuticals Financial Ratios

  • The Interest Expense is -1.11% of Operating Income.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Acumen Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ABOS
Website: acumenpharm.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ABOS Technical Analysis vs Fundamental Analysis

Sell
11
Acumen Pharmaceuticals (ABOS) is a Sell

Is Acumen Pharmaceuticals a Buy or a Sell?